• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 1
  3. Author

Online ISSN: 2515-8260

Volume9, Issue1

Assessment of Serum Trace Element (copper) Level, as an Associated Risk Factor in Patients with Chronic Kidney Disease.

    Dr. Ritika Gupta, Dr. Rinku Bansal, Dr. R.D. Mathur, Dr. Ajay Kumar Bhargava

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 1, Pages 1320-1325

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Background: Chronic Kidney Disease (CKD) is a progressive loss of kidney function and is a worldwide public health problem both for the number of patients and for the cost of treatment. Trace elements such as copper (Cu) is altered in CKD. We assessed 100 subjects of both sex with different age groups, among them 50 are normal healthy controls (group 1) and 50 are CKD patients (group 2) from dialysis ward (medicine) S.R.G. Hospital, Jhalawar Medical College, Jhalawar (Raj.) Serum copper was estimated using Flame Atomic Absorption Spectrophotometer (AAS).
Results: Serum copper level was significantly low in CKD patients, mean ± SD (1.2041 ±0.46360) (p<0.05) when compared with the healthy control group (1.3823 ± 0.25259) (p<0.05). Gender had no significant effect on serum copper level, in males, (1.1992± 0.41431) and females (1.2146± 0.56946) (p>0.05).
Conclusion: This study shows that in CKD patients, trace elements derangement is important in the primary diagnosis of trace element dysfunction and medical management of CKD.
Keywords:
  • PDF (155 K)
  • XML
(2022). Assessment of Serum Trace Element (copper) Level, as an Associated Risk Factor in Patients with Chronic Kidney Disease.. European Journal of Molecular & Clinical Medicine, 9(1), 1320-1325.
Dr. Ritika Gupta, Dr. Rinku Bansal, Dr. R.D. Mathur, Dr. Ajay Kumar Bhargava. "Assessment of Serum Trace Element (copper) Level, as an Associated Risk Factor in Patients with Chronic Kidney Disease.". European Journal of Molecular & Clinical Medicine, 9, 1, 2022, 1320-1325.
(2022). 'Assessment of Serum Trace Element (copper) Level, as an Associated Risk Factor in Patients with Chronic Kidney Disease.', European Journal of Molecular & Clinical Medicine, 9(1), pp. 1320-1325.
Assessment of Serum Trace Element (copper) Level, as an Associated Risk Factor in Patients with Chronic Kidney Disease.. European Journal of Molecular & Clinical Medicine, 2022; 9(1): 1320-1325.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 20
  • PDF Download: 22
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus